Testing a malaria drug in mice to prepare for brain tumor studies
Original title: Pharmacokinetics and Toxicity Assessment of Artesunate and Its Metabolite, Dihydroartemisinin, in NOD Scid Gamma Mice.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in healthy mice, and it did not test the drug on tumors.
The short version
Researchers checked whether a malaria drug was safe in healthy mice before testing it against brain tumors.
What was studied. The drug is called artesunate. It is already approved to treat malaria. Researchers gave it to healthy lab mice to see how much the mice could safely take. They also checked how the drug moved through the blood and into the brain.
What they found. A high dose of 350 mg/kg given as a shot into the belly caused no signs of harm in the mice. The drug and the substance the body turns it into got into the blood and brain fast. Both also left the body quickly. A shot put more of the drug into the blood and brain than a dose by mouth.
What this means, and what it doesn't
What it could mean: This work helps scientists plan future studies in mice with brain tumors. Because the drug leaves the body fast, those studies may need to give it more than once.
What it doesn't mean: This study did not test whether the drug works against brain tumors. It was done only in healthy mice, not in people. It is very early research and far from everyday care. It is not a cure, and it is not a reason to take this malaria drug for a brain tumor.
Source: PubMed, September 4, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.